Clinical Trial Update: An Open-label Study of Povetacicept in Participants With Autoimmune Cytopenias [Phase 1, Phase 2]

View source ↗

Summary

Open-label Phase 1/2 study evaluating povetacicept in autoimmune cytopenias. The study includes immune thrombocytopenia and idiopathic thrombocytopenic purpura,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cold Agglutinin Disease
• Idiopathic Thrombocytopenic Purpura
• Immune Thrombocytopenia
• Warm Autoimmune Hemolytic Anemia

Drugs mentioned

• Povetacicept (povetacicept)

Snippet

Sponsor: Alpine Immune Sciences, Inc. | Conditions: Immune Thrombocytopenia, Idiopathic Thrombocytopenic Purpura | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING